TOI
The Oncology Institute, Inc.
NASDAQ · USHealthcareMedical - Care Facilities
$5.50+2.80%
Price as of Jul 20, 2026
TOI profitability
The Oncology Institute, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 14.8%
- EBITDA margin
- -5.4%
- EBIT margin
- -6.0%
- Net margin
- -8.0%
- Free cash flow margin
- -4.7%
Returns
- Return on equity
- 267.2%
- Return on assets
- -25.9%
- Return on invested capital
- -36.9%
- Asset turnover
- 3.28x
Cash efficiency
- Cash from operations
- -$21.8M
- Cash per share
- $0.30
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.